THERAPEUTIC AGENT FOR B-LYMPHOMA AND HODGKIN LYMPHOMA

摘要

A cytotoxic agent or removing agent for a B-cell lymphoma cell or a Hodgkin lymphoma cell and a therapeutic agent for B-cell lymphoma or Hodgkin lymphoma comprising a monoclonal antibody capable of binding specifically to human CC chemokine receptor 4 (CCR4) or a fragment of the antibody as an active ingredient.